Pharos Energy (PHAR) Competitors

Pharos Energy (LON:PHAR) and Amryt Pharma (LON:AMYT) are both small-cap energy companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings.

Do institutionals and insiders hold more shares of PHAR or AMYT?

24.4% of Pharos Energy shares are owned by institutional investors. 51.3% of Pharos Energy shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Does the media refer more to PHAR or AMYT?

In the previous week, Pharos Energy had 2 more articles in the media than Amryt Pharma. MarketBeat recorded 2 mentions for Pharos Energy and 0 mentions for Amryt Pharma. Pharos Energy's average media sentiment score of 0.48 beat Amryt Pharma's score of 0.00 indicating that Pharos Energy is being referred to more favorably in the media.

Company	Overall Sentiment
Pharos Energy	Neutral
Amryt Pharma	Neutral

Which has better valuation and earnings, PHAR or AMYT?

Amryt Pharma has higher revenue and earnings than Pharos Energy. Pharos Energy is trading at a lower price-to-earnings ratio than Amryt Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pharos Energy	£196.07M	0.64	-£56.99M	-£9.40	-2.66
Amryt Pharma	£210.24M	0.00	N/A	-£33.00	N/A

Is PHAR or AMYT more profitable?

Amryt Pharma has a net margin of 0.00% compared to Pharos Energy's net margin of -29.06%. Amryt Pharma's return on equity of 0.00% beat Pharos Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pharos Energy	-29.06%	-16.16%	0.28%
Amryt Pharma	N/A	N/A	N/A

Does the MarketBeat Community prefer PHAR or AMYT?

Amryt Pharma received 221 more outperform votes than Pharos Energy when rated by MarketBeat users. However, 68.75% of users gave Pharos Energy an outperform vote while only 65.68% of users gave Amryt Pharma an outperform vote.

Company	Underperform	Outperform
Pharos Energy	Outperform Votes 22 68.75%	Underperform Votes 10 31.25%
Amryt Pharma	Outperform Votes 243 65.68%	Underperform Votes 127 34.32%

Summary

Pharos Energy beats Amryt Pharma on 8 of the 12 factors compared between the two stocks.